Healthcare -
Biotechnology - NASDAQ - US
$ 59.76
1.03 %
$ 7.36 B
Market Cap
17.42
P/E
HALO - CASH FROM OPERATIONS
Cash from Operations HALO - Halozyme Therapeutics, Inc.
479 M
LAST VALUE
41.25%
2 YEAR CAGR
50.06%
5 YEAR CAGR
28.30%
10 YEAR CAGR